InsiderFlow

II Robert C. Goeltz

RCUS

II Robert C. Goeltz serves as Chief Financial Officer at Arcus Biosciences, Inc. (RCUS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$826.9K

Net Position

Net Seller

$826.9K

Companies Traded

1

RCUS

Active Period

Dec 2021 – Dec 2025

8 total trades

Most Recent

Sell RCUS

Dec 31, 2025 · $153.2K

II Robert C. Goeltz's Insider Trading at Arcus Biosciences, Inc. (RCUS)

Buys

0 · $0.00

Sells

8 · $826.9K

Total Shares Bought

0

Total Shares Sold

37,420

RCUS Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Dec 31, 2025Sell6,552$23.38$153.2K0
Dec 16, 2025Sell12,662$22.01$278.7K0
Oct 28, 2025Sell5,000$20.00$100.0K0
Jan 3, 2025Sell3,594$15.00$53.9K60,138
Jan 4, 2024Sell2,004$20.00$40.1K51,831
Jun 9, 2023Sell4,049$20.04$81.1K59,392
Dec 16, 2022Sell2,453$30.75$75.4K11,953
Dec 20, 2021Sell1,106$40.12$44.4K7,771